prikaz prve stranice dokumenta National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
  Download
PDF 145.87 KB
Scientific paper - Original scientific paper
National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
HIV Medicine, 23 (2022), 5; 546-552. https://doi.org/10.1111/hiv.13194
Jilich, David; Skrzat‐Klapaczyńska, Agata; Fleischhans, Lukas; Bursa, Dominik; Antoniak, Sergii; Balayan, Tatevik; Begovac, Josip; Cicic, Alma; Dragovic, Gordana; Goekengin, Deniz; Harxhi, Arjan; Kase, Kerstin; Lakatos, Botond; Matulionyte, Raimonda; Mulabdic, Velida; Oprea, Cristiana; Papadopoulos, Antonios; Rukhadze, Nino; Tomazic, Janez; Tovba, Lida; Soják, Ľubomír; Vassilenko, Anne; Yancheva, Nina; Yurin, Oleg; Kowalska, Justyna More authors...

Cite this document

Jilich, D., Skrzat‐Klapaczyńska, A., Fleischhans, L., Bursa, D., Antoniak, S., Balayan, T. ... Kowalska, J. (2022). National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region. HIV Medicine, 23. (5), 546-552. doi: 10.1111/hiv.13194

Jilich, David, et al. "National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region." HIV Medicine, vol. 23, no. 5, 2022, pp. 546-552. https://doi.org/10.1111/hiv.13194

Jilich, David, Agata Skrzat‐Klapaczyńska, Lukas Fleischhans, Dominik Bursa, Sergii Antoniak, Tatevik Balayan, Josip Begovac, et al. "National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region." HIV Medicine 23, no. 5 (2022): 546-552. https://doi.org/10.1111/hiv.13194

Jilich, D., et al. (2022) 'National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region', HIV Medicine, 23(5), pp. 546-552. doi: 10.1111/hiv.13194

Jilich D, Skrzat‐Klapaczyńska A, Fleischhans L, Bursa D, Antoniak S, Balayan T, and sur.. National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region. HIV Medicine [Internet]. 2022 May [cited 2025 March 17];23(5):546-552. doi: 10.1111/hiv.13194

D. Jilich, et al., "National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region", HIV Medicine, vol. 23, no. 5, pp. 546-552, May 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:060139. [Accessed: 17 March 2025]

Please login to the repository to save this object to your list.
Metadata
Title (english)National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
AuthorDavid Jilich
AuthorAgata Skrzat‐Klapaczyńska
AuthorLukas Fleischhans
AuthorDominik Bursa
AuthorSergii Antoniak
AuthorTatevik Balayan
AuthorJosip Begovac
AuthorAlma Cicic
AuthorGordana Dragovic
AuthorDeniz Goekengin
AuthorArjan Harxhi
AuthorKerstin Kase
AuthorBotond Lakatos
AuthorRaimonda Matulionyte
AuthorVelida Mulabdic
AuthorCristiana Oprea
AuthorAntonios Papadopoulos
AuthorNino Rukhadze
AuthorJanez Tomazic
AuthorLida Tovba
AuthorĽubomír Soják
AuthorAnne Vassilenko
AuthorNina Yancheva
AuthorOleg Yurin
AuthorJustyna Kowalska
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Infectious Diseases)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Infectology
Abstract (english)
Introduction: People living with HIV (PLWH) are at higher risk of poorer COVID-19 outcomes. Vaccination is a safe and effective method of prevention against many infectious diseases, including COVID-19. Here we investigate the strategies for national COVID-19 vaccination programmes across central and eastern Europe and the inclusion of PLWH in vaccination programmes. ----- Methods: The Euroguidelines in Central and Eastern Europe Network Group consists of experts in the field of infectious diseases from 24 countries in the region. Between 1 November 2020 and 19 March 2021 the group proceeded an on-line survey consisting of 20 questions. ----- Results: Twenty-two countries (out of 24 invited) participated in the survey and 20/22 countries in the period between December 2020 and March 2021 had already started their COVID-19 vaccination programme. In total, seven different vaccines were used by participating countries. In 17/21 countries (81%), vaccinated persons were centralized within the national registry. In 8/21 countries (38%) PLWH were prioritized for vaccination (the Czech Republic, Greece, Hungary, Lithuania, Montenegro, Romania, Slovakia, Slovenia) and the Czech Republic, Greece and Serbia had put in place national guidelines for vaccination of PLWH. In 14/20 countries (70%) vaccination was only provided by designated centres. Eighteen respondents (18/21; 85.7%) reported that they planned to follow up HIV patients vaccinated against COVID-19, mainly by measuring antibody levels and checking COVID-19 incidence (11/21; 52.3%). ----- Conclusions: This survey-based study suggests that there are significant differences in terms of prioritizing PLWH, the types of vaccines used, vaccination coverage, and the development and implementation of a vaccination programmes within the region. Regardless of heterogenicity and existing barriers within the region, systematic vaccination in PLWH should have the highest priority, especially in those with severe immunodeficiency, risk factors, and in the elderly, aiming for prompt and high vaccination coverage.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleHIV Medicine
Numberingvol. 23, no. 5, pp. 546-552
p-ISSN1464-2662
e-ISSN1468-1293
DOIhttps://doi.org/10.1111/hiv.13194
URN:NBNurn:nbn:hr:105:060139
Publication2022-05
Document URLhttps://onlinelibrary.wiley.com/doi/10.1111/hiv.13194
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2022-06-28 07:44:29